stockportfolio.pro logostockportfolio.pro Start 7-day free trial
Stocks / JNJ

Johnson & Johnson (JNJ)

Healthcare · Drug Manufacturers - General · NYSE

Price
$232.16
Market Cap
$558.86B
P/E Ratio
26.87
EPS
$8.64
Sector
Healthcare
52-Week High
$251.71
52-Week Low
$149.04
Dividend Yield
2.30%

Johnson & Johnson revenue & earnings (annual)

Metric2025202420232022
Revenue$94.19B$88.82B$85.16B$94.94B
Gross profit$0$0$0$0
Net income$26.80B$14.07B$35.15B$17.94B

See the full financials for Johnson & Johnson

Full income statement, balance sheet and cash flow (28+ line items across multiple years), an interactive price & market-cap chart, valuation ratios, and the ability to track JNJ in your own portfolio.

Start your 7-day free trial

Open JNJ in the full fundamentals view →

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Explore more stocks

Browse all 500+ companies →